Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis

Research output: Contribution to journal › Review › Research › peer-review

Standard

Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis. / Weinreich, Ulla Møller; Ulrik, Charlotte Suppli; Skjold, Tina; Christensen, Niels Lyhne.

In: Ugeskrift for Laeger, Vol. 184, No. 2, V09210680, 10.01.2022.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Weinreich, UM, Ulrik, CS, Skjold, T & Christensen, NL 2022, 'Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis', Ugeskrift for Laeger, vol. 184, no. 2, V09210680. <https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-01/v09210680_web.pdf>

APA

Weinreich, U. M., Ulrik, C. S., Skjold, T., & Christensen, N. L. (2022). Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis. Ugeskrift for Laeger, 184(2), [V09210680]. https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-01/v09210680_web.pdf

Vancouver

Weinreich UM, Ulrik CS, Skjold T, Christensen NL. Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis. Ugeskrift for Laeger. 2022 Jan 10;184(2). V09210680.

Author

Weinreich, Ulla Møller ; Ulrik, Charlotte Suppli ; Skjold, Tina ; Christensen, Niels Lyhne. / Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis. In: Ugeskrift for Laeger. 2022 ; Vol. 184, No. 2.

Bibtex

@article{1b976b38743749b3ac839340c5bd9e24,
title = "Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis",
abstract = "The anti-inflammatory effect of systemic corticosteroid (CS) on obstructive lung diseases and seasonal allergic rhinitis is well known. So are the physiological side-effects of CS. A major development in inhalation and biologic treatment as well as hyposensibilisation has taken place in recent years and evidence of personalized use of CS in acute exacerbations increases. We review the side effects of CS and the rationale for use of systemic CS in treatment of obstructive lung diseases as asthma and COPD, as well as seasonal allergic rhinitis.",
keywords = "Administration, Inhalation, Adrenal Cortex Hormones/adverse effects, Asthma/drug therapy, Humans, Rhinitis, Allergic/drug therapy, Rhinitis, Allergic, Seasonal/drug therapy",
author = "Weinreich, {Ulla M{\o}ller} and Ulrik, {Charlotte Suppli} and Tina Skjold and Christensen, {Niels Lyhne}",
year = "2022",
month = jan,
day = "10",
language = "Dansk",
volume = "184",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "2",

}

RIS

TY - JOUR

T1 - Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis

AU - Weinreich, Ulla Møller

AU - Ulrik, Charlotte Suppli

AU - Skjold, Tina

AU - Christensen, Niels Lyhne

PY - 2022/1/10

Y1 - 2022/1/10

N2 - The anti-inflammatory effect of systemic corticosteroid (CS) on obstructive lung diseases and seasonal allergic rhinitis is well known. So are the physiological side-effects of CS. A major development in inhalation and biologic treatment as well as hyposensibilisation has taken place in recent years and evidence of personalized use of CS in acute exacerbations increases. We review the side effects of CS and the rationale for use of systemic CS in treatment of obstructive lung diseases as asthma and COPD, as well as seasonal allergic rhinitis.

AB - The anti-inflammatory effect of systemic corticosteroid (CS) on obstructive lung diseases and seasonal allergic rhinitis is well known. So are the physiological side-effects of CS. A major development in inhalation and biologic treatment as well as hyposensibilisation has taken place in recent years and evidence of personalized use of CS in acute exacerbations increases. We review the side effects of CS and the rationale for use of systemic CS in treatment of obstructive lung diseases as asthma and COPD, as well as seasonal allergic rhinitis.

KW - Administration, Inhalation

KW - Adrenal Cortex Hormones/adverse effects

KW - Asthma/drug therapy

KW - Humans

KW - Rhinitis, Allergic/drug therapy

KW - Rhinitis, Allergic, Seasonal/drug therapy

M3 - Review

C2 - 35023467

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 2

M1 - V09210680

ER -

ID: 325840165